Phase II-trial DIAGNODE-2 ahead of World Diabetes Day now open to include patients

Diamyd Medical's pivotal trial DIAGNODE-2 is now open for booking patients. The diabetes vaccine Diamyd® for intralymphatic administration will be delivered to the clinics participating in the trial that can begin screening patients. DIAGNODE-2 comprises about 80 patients from Spain, the Czech Republic and Sweden between the ages of 12-24 who have been diagnosed with type 1 diabetes in the last 6 months.“Given the highly promising data we have seen from DIAGNODE-1, it is of course a great event and a potential opportunity for diabetes patients, and we are particularly pleased that we can